Etodolac Capsule (Etodolac)

Adult dose

Acute symptoms: Adults: Administer etodolac 200-400mg orally per dose, 3-4 times daily (every 6-8 hours). Chronic symptoms: The initial dose is 800-1200mg per day orally in 2-4 divided doses; the maintenance dose is 600-1200mg per day orally in 2-4 divided doses. Do not exceed 1200mg per day. Adjust the dose as appropriate according to age and symptoms.

This medication may pose a risk of gastrointestinal bleeding in individuals who consume three or more alcoholic beverages daily, so it is essential to consult a doctor or pharmacist before use. This medication can affect the cardiovascular system and increase the risk of serious cardiovascular diseases such as myocardial infarction or stroke, so individuals with heart conditions or risk factors should exercise particular caution. Since ulcers or bleeding may occur in the gastrointestinal tract, individuals with a history of gastrointestinal disorders or elderly patients should carefully monitor any symptoms while taking this medication. Patients with a history of peptic ulcers or bleeding, allergies to this medication or similar drugs, or a history of asthma or allergic reactions should not take this medication. Individuals with impaired kidney or liver function, or symptoms of hypotension or heart failure should consult a doctor before taking this medication and use it cautiously. During the course of this medication, if symptoms such as nausea, diarrhea, headaches, skin rashes, or difficulty breathing occur, immediate medical attention should be sought. Especially in the late stages of pregnancy, this medication may affect the fetus, so pregnant individuals should avoid using it, and nursing mothers should also be cautious as this medication may be passed through breast milk. This medication can interact with other drugs, so if you are currently taking other medications, it is crucial to inform your doctor or pharmacist, especially when taking it with blood pressure medications, anticoagulants, or diuretics. Safety in children has not been established, and elderly patients should exercise caution regarding dosage adjustment and monitoring. In case of overdose, symptoms such as gastrointestinal bleeding, drowsiness, nausea, and vomiting may occur, and immediate treatment in a medical facility is necessary. This medication should be kept out of reach of children.

Gastrointestinal bleeding, ulcer, perforation, nausea, diarrhea, upper abdominal pain, loss of appetite, hepatitis, jaundice, belching, elevated liver enzymes, heartburn, dyspepsia, bloating, abdominal pain, gastrointestinal cramps, abdominal gas accumulation, constipation, gastritis, bloody stools, thirst, dry mouth, ulcerative stomatitis, black tongue syndrome, vomiting, esophagitis accompanied by stricture or pyloric spasm, colitis, ischemic or ulcerative colitis, colon ulcer, pseudomembranous colitis, pancreatitis, headache, dizziness, drowsiness, insomnia, nervousness, anxiety, depression, asthenia, malaise, hypersomnia, paralysis, coma, sensory disturbances, confusion, pruritus, rash, angioedema, sweating, urticaria, vesicular rash, subcutaneous vasculitis accompanied by purpura, Stevens-Johnson syndrome, hyperpigmentation, erythema multiforme, hair loss, skin desquamation, maculopapular rash, photosensitivity, nipple necrosis, chills, fever, fatigue, weakness, discomfort, allergic reaction, anaphylactic reaction, infection, dysuria, frequent urination, renal failure, renal impairment, renal papillary necrosis, cystitis, hematuria, leukorrhea, kidney stones, interstitial nephritis, irregular uterine bleeding, blurred vision, lifespan, tinnitus, photophobia, transient visual disturbances, conjunctivitis, hearing loss, taste disturbance, hypotension, hypertension, congestive heart failure, flushing, tachycardia, palpitations, syncope, vasculitis, petechial hemorrhage, anemia, thrombocytopenia, prolonged bleeding time, agranulocytosis, hemolytic anemia, leukopenia, neutropenia, pancytopenia, arrhythmia, myocardial infarction, fluid retention, cerebrovascular accident, asthma, bronchitis, dyspnea, pharyngitis, rhinitis, sinusitis, venous thrombophlebitis, edema, elevated serum creatinine, weight change, hyperglycemia, drowsiness, phenomena, external heart pain, epigastric pain, respiratory depression, coma

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

A hard capsule with a light gray upper part and a dark gray lower part containing white granules or powder

Package unit

30 capsules/bottle, 500 capsules/bottle, 50 capsules (10 capsules/PTP×5, for export)